Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave

Abstract

ObjectiveTo better define the immunopathogenesis of COVID-19, the present study aims to characterize the early immune responses to SARS-CoV-2 infection in household contacts of COVID-19 cases. In particular, innate, T- and B-cell specific responses were evaluated over time.MethodsHousehold contacts of COVID-19 cases screened for SARS−CoV−2 infection by nasopharyngeal swab for surveillance purposes were enrolled (T0, n=42). Of these, 28 subjects returned for a follow-up test (T1). The innate response was assessed by detecting a panel of soluble factors by multiplex-technology in plasma samples. Cell-mediated response was evaluated by measuring interferon (IFN)-γ levels by ELISA in plasma harvested from whole-blood stimulated with SARS−CoV−2 peptide pools, including spike (S), nucleocapsid (N) and membrane (M) proteins. The serological response was assessed by quantifying anti-Receptor-Binding-Domain (RBD), anti-Nucleocapsid (N), whole virus indirect immunofluorescence, and neutralizing antibodies.ResultsAt T0, higher levels of plasmatic IFN-α, IL-1ra, MCP-1 and IP-10, and lower levels of IL-1β, IL-9, MIP-1β and RANTES were observed in subjects with positive swab compared to individuals with a negative one (p<0.05). Plasmatic IFN-α was the only cytokine detectable in subjects with positive SARS-CoV-2 swabs with high accuracy for swab score positivity (0.93, p<0.0001). Among subjects with positive swabs, significant negative correlations were found among the RT-PCR cycle threshold values reported for genes S and N and IFN-α or IP-10 levels. At T0, the IFN-γ T-cell specific response was detected in 50% (5/10) of subjects with positive swab, while anti-RBD/anti-N antibodies showed a positivity rate of 10% (1/10). At T1, the IFN-γ T-cell specific response was detected in most of the confirmed-infection subjects (77.8%, 7/9), whereas the serological response was still observed in a minority of them (44.4%, 4/9). Overall, the swab test showed a moderate concordance with the T-cell response (78.6%, k=0.467), and a scarce concordance with the serological one (72.9%, k=0.194).ConclusionsPlasmatic IFN-α and the IFN-γ T-cell specific response appear early even in the absence of seroconversion, and show a greater positivity rate than the serological response in household contacts with positive swab.

Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis

“…In terms of innate immunity, the cytokines in COVID-19 exert both antiviral and inflammatory activities and promote disease-associated processes directly, such as epithelial cell death and immunothrombosis. Following SARS-CoV-2 exposure, the type I IFN production is increased ( 85 – 88 ). However, patients with severe COVID-19 have altered innate immune function, such as a reduced gene expression (i.e.…”

Emerging viral infections in immunocompromised patients: A great challenge to better define the role of immune response

“…anti-CD20 monoclonal antibody, anti-CD19 CAR T cells) was associated with the worst humoral response to vaccination, making these patients particularly vulnerable to SARS-CoV-2 infection. In contrast, spike-specific T-cell response is less susceptible to both diseases and treatment, highlighting its main role as a backbone of the immune response also in highly IC patients where they can exert a protective activities against the severe COVID-19 ( 35 , 39 , 80 ). The booster doses (third and fourth doses) improved the humoral response in all disease groups, although to a lesser extent in patients with hematological malignancies, whereas the T-cell response increased similarly in all IC groups ( 39 , 81 ).…”

Insights into COVID-19 and Its Potential Implications for Kidney Dysfunction

“…From the mild to the severe stages, COVID-19 disease was found to have varying levels of pro-inflammatory cytokines and chemokines [103]. In SARS-CoV-2-infected patients, a retrospective analysis revealed higher expression levels of IL-1β, IL-1RA, IL-7, IL-8, IL-10, IFN-G, monocyte chemoattractant peptide (MCP)-1, granulocyte-colony stimulating factor (G-CSF), macrophage inflammatory protein (MIP)-1A, MIP-1B, and tumor necrosis factor-alpha (TNF-α) [105]. Furthermore, the severity of lung injury was strongly associated with increased plasma levels of IL-1α, IL-1ra, IL-2, IL-7, IL-10, IL-17, IFN-G, inducible interferon protein (IP)-10, and G-CSF, which are positively related to SARS-CoV-2 viral titers.…”